TY - JOUR
T1 - Impact of Caffeine on Overactive Bladder Symptoms
AU - Palma, Imari Ashley F.
AU - Staack, Andrea
N1 - Publisher Copyright:
© 2016, Springer Science+Business Media New York.
PY - 2016/3/1
Y1 - 2016/3/1
N2 - Caffeine consumption is highly prevalent in the adult population. First-line treatment of overactive bladder (OAB) symptoms involves behavioral modification, which includes reduction of caffeine consumption. A literature review over the last 3 years has identified 10 peer-reviewed articles that investigated the effects and mechanisms of caffeine on OAB symptoms. The literature describes that caffeine can be associated to de novo OAB symptoms or their exacerbation. Those effects have been found to be dose dependent. Significant associations to age and gender cannot be made at this point due to limited studies. This review raises awareness of caffeine’s potential causal impact on OAB symptoms, which is important when counseling the general population and patients suffering from OAB. Since there is a lack of evidence-based data to support clinical recommendations, more controlled-randomized prospective studies are needed to assess the impact of caffeine on OAB symptoms that also control for dose, gender, and age.
AB - Caffeine consumption is highly prevalent in the adult population. First-line treatment of overactive bladder (OAB) symptoms involves behavioral modification, which includes reduction of caffeine consumption. A literature review over the last 3 years has identified 10 peer-reviewed articles that investigated the effects and mechanisms of caffeine on OAB symptoms. The literature describes that caffeine can be associated to de novo OAB symptoms or their exacerbation. Those effects have been found to be dose dependent. Significant associations to age and gender cannot be made at this point due to limited studies. This review raises awareness of caffeine’s potential causal impact on OAB symptoms, which is important when counseling the general population and patients suffering from OAB. Since there is a lack of evidence-based data to support clinical recommendations, more controlled-randomized prospective studies are needed to assess the impact of caffeine on OAB symptoms that also control for dose, gender, and age.
KW - Age
KW - Caffeine
KW - Caffeine dose
KW - Counseling
KW - Gender
KW - Overactive bladder symptoms
UR - http://www.scopus.com/inward/record.url?scp=84961618623&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84961618623&partnerID=8YFLogxK
U2 - 10.1007/s11884-016-0342-y
DO - 10.1007/s11884-016-0342-y
M3 - Review article
SN - 1931-7212
VL - 11
JO - Current Bladder Dysfunction Reports
JF - Current Bladder Dysfunction Reports
IS - 1
ER -